Turnaround and Transformation Survey

Companies in many regions remain mired in challenges driven by the rapid rise in the cost of capital. Criticaleye Partner AlixPartners' 19th Annual Turnaround and Transformation Survey sees more than 700 of the world's restructuring experts, and executives say that the cost of capital is still the biggest factor driving company distress. However, that is just one part of the emerging story.

Key Takeaways Include:

  • Which sector globally is most likely to face distress in 2024? 
  • 82 percent expect the cost of capital to remain at current levels or increase further, while 18 percent expect it to decrease.
  • 72 percent say restructuring capital structure or moving assets is the most likely liability management technique to be activated in the next 12 months to mitigate risk.




Related Insights

Read, watch & listen to some of the latest thought leadership from our Community.

Click here to download this insight
Europe's AI Reckoning: Reinve...

Europe’s productivity challenge is growing and the clear root cause is underinvestment in technology. In this report, Criticaleye Partner Accenture explores the potential of artificial intelligence (AI) to bo...

Click here to download this insight
Are Women Leaders Driving our...

How are women leaders responding to disruption in today’s uncertain world? This report from Criticaleye Partner AlixPartners draws on insights from its latest Disruption Index to reveal that women in leadership ar...

Click here to download this insight
CEO Research Results 2025

This research, conducted at our CEO Retreat, subtitled When Leadership Goes Faster, provides a fascinating insight into the challenges and priorities for CEOs this year. Key findings from Criticaleye's CEO Resear...


1 2 3 4 5 6 7 8 9 10
Displaying 1 to 3 of 414




Google Lightsource bp Hitachi Solutions Salesforce Drax Group plc NATS FTSE Women Leaders Review Workday Eightfold AI London Stock Exchange Group E.ON UK Concentrix Palo Alto Networks LDC Redwood Bank Legal & General Investment Management Experian GlaxoSmithKline plc Rolls-Royce Royal London Group AlixPartners Accenture IBM Consulting Amazon UK